Last updated on August 2017

Chronic Refractory Cough

Brief description of study

Chronic Refractory Cough

Detailed Study Description

A double-blind, randomized, placebo-controlled study of the efficacy and safety of three doses of Orvepitant in subjects with chronic refractory cough.

Clinical Study Identifier: TX151873

Contact Investigators or Research Sites near you

Start Over

Cherish Semeski

Vital Prospects Clinical Research Institute, P.C.
Tulsa, OK USA
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.